Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

PACCAR Inc

PCAR

FAVORABLE

May 27, 2026

Research Conclusion

ACCUMULATE at $87. PWFV ~$99 (+14%). Composite FV ~$97-107 (+12-23%). BUY below $75. Strong Add below $65. PACCAR at $87 is a high-quality cyclical industrial at a trough valuation. FY2025 was the freight cycle bottom ($5.01 adj. EPS); the recovery path to normalized $7.50-8.50 EPS offers 30-50% EPS expansion. The EPA 2027 pre-buy optionality (potentially $9-10 EPS in FY2027-2028) is not fully priced. The Parts segment (55% of pretax income on 24% of revenue, growing structurally) provides a quality floor that prevents the stock from trading at distressed multiples.

Company Overview & Moat Assessment

PACCAR Inc is the world's second-largest heavy-duty truck manufacturer, operating three premium brands: Kenworth (US/Canada), Peterbilt (US/Canada), and DAF (Europe/global). Three segments: Trucks (~68% of FY2025 revenue, cyclical), Parts (~24%, counter-cyclical, structural growth), Financial Services (~8%, captive financing). Founded 1905; 86 consecutive years of net income. FY2025 (cyclical trough): Revenue $28.44B (-15.5%); adj. EPS $5.01; FCF $3.029B; Parts revenue $6.87B (10th consecutive record, 24% pretax margin). NA Class 8 market share: ~30.7% combined. Dividends: $2.72/share declared FY2025. The Pigott family maintains cultural board influence (~118+ years of ownership). FY2026 NA Class 8 market guide: 230,000-270,000 trucks. The EPA 2027 pre-buy represents the key potential re-rating catalyst.

▲ Bull Case

  • EPA 2027 pre-buy delivers 50K+ incremental NA units: NA Class 8 market spikes to 330-350K; PACCAR deliveries exceed 200K; adj. EPS reaches $9.50-10.00 FY2027; market applies 14-15x forward earnings — target $135-150 (+55-72%)
  • Parts segment re-rated as 'recurring revenue' at 18-20x EPS equivalent: separate Parts valuation at 20x → $33B; Trucks at normalized 10x → $23B; combined = $56B / ~$107/share vs. current $46B — target $115-120 (+32-38%)
  • Amplify JV + DAF EV market leadership in Europe: PACCAR's 30% stake in Amplify Cell Technologies enables cost-competitive EV drivetrains; DAF XD/XF Electric wins continue (International Truck of Year 2026); multiple re-rates away from EV-disruption discount — target $115+ (+32%)

▼ Bear Case

  • EPA 2027 delayed by administration + freight stays depressed: current administration modifies GHG Phase 3; pre-buy catalyst disappears; freight rates remain suppressed through FY2027; adj. EPS stays at $5.00; P/E 11x — target $55 (-37%)
  • Tesla Semi ramp to 20K+ units/yr + EU CO2 mandates accelerate: large US fleets begin 10-20% EV commitments; PACCAR MX engine revenue begins secular decline; multiple de-rates to 9-10x on ICE-cycle concerns — target $60-70 (-20-31%)
  • Freight recession + Parts disappointment: fleet bankruptcies compress installed base; Parts revenue turns negative for first time in 10 years; EC litigation surprise adds $400M+ charge; adj. EPS $3.25; P/E 10x — target $32 (-63%)
Primary Debate on Wall Street

The primary debate is whether the EPA 2027 pre-buy is a near-certainty (historical pattern repeating) or regulatory uncertainty that makes PCAR a value trap at $87. Bull view: every EPA emissions regulation since 1988 has generated a pre-buy; rational fleet operators consistently choose known-quantity trucks over new-technology uncertainty; PCAR at $87 prices in no pre-buy — essentially free optionality. Bear view: EPA regulatory certainty in 2026 differs from prior cycles; the current administration has shown willingness to reverse or delay EPA rules; if EPA 2027 is delayed to 2029-2030, the pre-buy is deferred 2-3 years and PCAR at $87 is fairly valued with no free optionality. Our view: the market is pricing roughly 30-40% probability of a pre-buy at current levels; historical pre-buy magnitude has always exceeded initial expectations once fleet operators start ordering; Pigott-family financial discipline means PACCAR earns through the trough even under a regulatory delay — ACCUMULATE at $87, add aggressively if pre-buy clarity emerges in H2 2026.

Top Catalysts
  • EPA 2027 GHG Phase 3 regulatory status clarity (H2 2026) — binary catalyst; if proceeds as written, pre-buy drives EPS to $9-10 and target of $135-150
  • Parts segment Q2-Q4 2026 record confirmation (11th consecutive year) — validates structural growth thesis
  • H2 2026 fleet order intake surge — leading indicator of EPA pre-buy materializing before formal regulatory announcement
  • FY2026 NA Class 8 market actuals vs. 230-270K guide — confirms freight recovery pace
  • Amplify JV first LFP battery production signal (2027-2028) — validates EV hedge strategy and optionality
  • Q1 2026 earnings already confirmed revenue stabilization — positive baseline established
Top Risks
  • EPA 2027 regulatory delay >12 months (35% probability, High) — removes primary re-rating catalyst; pre-buy deferred not canceled, but stock loses near-term upside driver
  • Freight recession / GDP contraction (20% probability, High) — pressures truck volumes; Parts counter-cyclical offset and fortress balance sheet are mitigants
  • Tesla Semi production exceeds 30K annual units (20% probability, Moderate) — narrative inflection point accelerating EV disruption timeline for fleet purchasing discussions
  • EU CO2 mandates accelerate DAF EV capex requirements (30% probability, Moderate) — increases capital intensity; Amplify JV and DAF EV leadership are partial mitigants
  • Additional EC civil litigation charges (10% probability, Moderate — $200-400M range) — prior settlement paid; no identified new proceedings currently
  • Special dividend suspension if earnings trough extends (25% probability, Low) — regular dividend floor ($1.32/yr) has never been cut in 86 years; special is discretionary
  • North American Class 8 market share loss (10% probability, Moderate) — 15+ years of stable 28-32% share; Kenworth/Peterbilt brand loyalty is structural mitigant

Full Memo Continues

5 more sections, locked

  • Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/PCAR/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.